<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Benign <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsy</z:e> with centrotemporal spikes (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BECTS</z:e>), also known as <z:e sem="disease" ids="C0376532" disease_type="Disease or Syndrome" abbrv="BECTS">benign rolandic epilepsy</z:e> (BRE) of childhood represents 15% of <z:hpo ids='HP_0000001'>all</z:hpo> childhood <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epilepsies</z:e> [Handbook of <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">Epilepsy</z:e> Treatment (2000)] </plain></SENT>
<SENT sid="1" pm="."><plain>A majority of these patients do no require treatment; however, in those cases where treatment is justified, the most efficacious medication with a benign safety profile should be selected </plain></SENT>
<SENT sid="2" pm="."><plain>We present three clinical cases of otherwise healthy children with <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BECTS</z:e> who were treated only with levetiracetam </plain></SENT>
<SENT sid="3" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> three of these children remain <z:hpo ids='HP_0001250'>seizure</z:hpo>-free and are experiencing no reported side effects </plain></SENT>
</text></document>